Case-Based Panel Discussion: Non-Muscle Invasive Bladder Cancer

Seth P. Lerner, MD, Guilherme Godoy, MD, MS, and Jennifer M. Taylor, MD, MPH, presented “Case-Based Panel Discussion: Non-Muscle Invasive Bladder Cancer” during the 24th Annual Innovations in Urologic Practice on September 14, 2019 in Santa Fe, New Mexico.

How to cite: Lerner, Seth P., Godoy, Guilherme, and Taylor, Jennifer M. “Case-Based Panel Discussion: Non-Muscle Invasive Bladder Cancer” September 14, 2019. Accessed Nov 2019. https://grandroundsinurology.com/case-based-panel-discussion-non-muscle-invasive-bladder-cancer​/

Case-Based Panel Discussion: Non-Muscle Invasive Bladder Cancer – Summary:

Seth P. Lerner, MD, Guilherme Godoy, MD, MS, and Jennifer M. Taylor, MD, MPH, take part in a panel discussion consisting of two case studies of non-muscle invasive bladder cancer, focusing on BCG usage for high-risk patients and immediate intravesical post-operative chemotherapy instillation for medium-risk patients.

Abstract:

In the first case presented in this panel discussion, Dr. Taylor discusses a 73-year-old male patient with a high-risk pathology profile who underwent conventional BCG treatment that failed to prevent a recurrence of disease. Dr. Lerner details the reasons for the shortage of BCG and the benefits of early radical cystectomy on patient survival, as well as alternative treatments to radical cystectomy and FDA guidelines for trials of these treatments.

In the second case, Dr. Taylor presents a 76-year-old female patient with a medium-risk profile who was not a candidate for BCG treatment due to the aforementioned shortage. Dr. Godoy outlines alternative treatment options, focusing on immediate intravesical post-operative chemotherapy instillation as a well-tested treatment to decrease the risk of recurrence (rather than progression) of disease in these patients. Additionally, he explains why this treatment is currently under-utilized.

About the 24th Annual Innovations in Urologic Practice

Innovations in Urologic Practice (Innovations) is an annual, multi-day, CME-accredited conference devoted to innovative diagnostic and treatment strategies for and controversies related to some of the most common urologic problems in the current era. The topics covered include oncological management of the bladder, kidney, and prostate. The conference also emphasizes general urology topics in pelvic reconstruction and trauma, men’s health, and infections in the urology patient. Drs. Lerner, Godoy, and Taylor presented this lecture during the 24th Innovations in 2019. Please visit this page in order to register for future Innovations meetings.